Twist Bioscience Q3 Results Top Estimates
(RTTNews) - Genomics company Twist Bioscience Corp. (TWST) reported Friday a net loss attributable to common stockholders for the third quarter of $60.52 million or $1.08 per share, wider than $40.04 million or $0.82 per share in the prior-year quarter.
On average, seven analysts polled by Thomson Reuters expected the company to report a loss of $1.31 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues for the quarter increased to $56.11 million from $35.02 million in the same quarter last year. Analysts expected revenues of $51.45 million for the quarter.
Looking ahead to fiscal 2022, the company now projects revenue of approximately $203 million, up from the prior guidance range of $191 million to $199 million.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Twist Bioscience Inks Antibody Discovery, Option And License Deal With Bayer For Up To $188 Mln
U.S. Dollar Ticks Lower As Investors Monitor Developments In Middle East
TSX Drops Nearly 2.5%; Materials, Tech Stocks Down Sharply
Swiss Market Ends Modestly Higher
Major European Markets End Mixed As Investors React To Earnings, Economic Data
Chicago Business Barometer Pulls Back But Still Indicates Growth In October
Colgate-Palmolive Q3 Results Rise, Lifts FY26 Base Business EPS View; Stock Gains
